insertable cardiac monitor (96% of patients kept it after 12 months)
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2014 Jun 26;370(26):2478-86 Randomized Controlled Trial, Multicenter Study
IN stroke, ischemic, cerebral infarction, transient ischemic attack, cryptogenic, embolic, atrial fibrillation The Use of
insertable cardiac monitor (96% of patients kept it after 12 months)
As Diagnostic Tool
Is better Than
conventional ECG follow-up at the discretion of usual doctor
To detect atrial fibrillation at 12 months : 12% of patietns with insertable monitor VS 2% in controls. Insertable monitors had to be removed in 2.4% patients because infection or local inflammation.